<p>Oscar Health, Inc.（紐約證券交易所代碼：OSCR - 獲取免費報告）內部人士 Mario Schlosser 於 12 月 2 日（星期二）出售了 23,965 股公司的股票。該股票的平均售價為 16.59 美元，總交易額為 397,579.35 美元。出售完成後，該內部人士在公司持有 477,183 股，價值 7,916,465.97 美元。這代表其持股比例減少了 4.78%。該交易已在與證券交易委員會的法律文件中披露，您可以通過此鏈接訪問。</p>
<ul>
<li>5 只具有爆炸性上漲潛力的小型股</li>
</ul>
<p>Mario Schlosser 最近還進行了以下交易：</p>
<ul>
<li>在 11 月 11 日（星期二），Mario Schlosser 出售了 286,182 股 Oscar Health 股票。該股票的平均售價為 15.27 美元，總價值為 4,369,999.14 美元。</li>
<li>在 9 月 22 日（星期一），Mario Schlosser 出售了 395,000 股 Oscar Health 股票。該股票的平均售價為 18.43 美元，總價值為 7,279,850.00 美元。</li>
</ul>
<h2>Oscar Health 股票表現</h2>
<p>OSCR 股票在週四的午盤交易中上漲了 0.07 美元，達到 17.17 美元。該股票的交易量為 7,737,399 股，而其平均交易量為 14,589,062 股。Oscar Health, Inc.的股價一年低點為 11.20 美元，一年高點為 23.80 美元。該公司的市值為 45.5 億美元，市盈率為-15.33，貝塔值為 1.88。該公司的 50 日簡單移動平均線為 18.08 美元，200 日簡單移動平均線為 16.93 美元。公司的速動比率為 0.92，流動比率為 0.92，債務與股本比率為 0.67。</p>
<p>Oscar Health（紐約證券交易所代碼：OSCR - 獲取免費報告）最近在 11 月 6 日（星期四）發佈了其財報。公司報告本季度每股收益（EPS）為（0.53）美元，超出市場共識預期的（0.55）美元，超出幅度為 0.02 美元。該季度公司的收入為 29.3 億美元，而分析師預期為 30.9 億美元。Oscar Health 的股本回報率為-21.50%，淨利潤率為-2.16%。與去年同期相比，Oscar Health 的季度收入增長了 23.2%。去年同期，該公司每股收益為（0.22）美元。分析師平均預測 Oscar Health, Inc.本年度將發佈 0.69 美元的每股收益。</p>
<h2>機構投資者對 Oscar Health 的看法</h2>
<p>一些機構投資者最近對 OSCR 的持倉進行了調整。美國世紀公司在第三季度將其在 Oscar Health 的持倉增加了 89.0%。美國世紀公司目前擁有 5,298,340 股該公司的股票，價值 100,298,000 美元，此前在上個季度又購買了 2,495,691 股。Nuveen LLC 在第一季度獲得了 Oscar Health 的新持倉，價值約 29,684,000 美元。Farallon Capital Management LLC 在第三季度將其在 Oscar Health 的持倉增加了 146.5%。Farallon Capital Management LLC 目前擁有 3,639,000 股該公司的股票，價值 68,886,000 美元，此前在上個季度又購買了 2,163,000 股。Thrive Capital Management LLC 在第四季度將其在 Oscar Health 的持倉提高了 33.4%。Thrive Capital Management LLC 目前擁有 6,343,617 股該公司的股票，價值 85,258,000 美元，此前在該期間又購買了 1,588,395 股。最後，密歇根州退休系統在第三季度購買了 Oscar Health 的新股份，價值 27,448,000 美元。75.70% 的股票由機構投資者和對沖基金持有。</p>
<h2>分析師的升級和降級</h2>
<p>幾位研究分析師最近對該股票發佈了報告。富國銀行將 Oscar Health 的目標股價從 14.00 美元下調至 11.00 美元，並在 11 月 13 日（星期四）的研究報告中對該公司給予了 “減持” 評級。高盛集團在 10 月 14 日（星期二）對 Oscar Health 進行了覆蓋，給予了 “中性” 評級和 17.00 美元的目標價格。派珀·桑德勒將 Oscar Health 的評級從 “中性” 上調至 “增持”，並在 11 月 25 日（星期二）的研究報告中將其目標價格從 13.00 美元提高至 25.00 美元。瑞銀集團將 Oscar Health 的目標價格從 11.00 美元上調至 12.00 美元，並在 11 月 7 日（星期五）的研究報告中給予該公司 “賣出” 評級。最後，巴克萊將 Oscar Health 的目標價格從 11.00 美元上調至 13.00 美元，並在 11 月 10 日（星期一）的研究報告中給予該股票 “減持” 評級。一位分析師對該股票給予了買入評級，五位分析師給予了持有評級，五位分析師給予了賣出評級。根據 MarketBeat.com 的數據，Oscar Health 目前的共識評級為 “減持”，共識目標價格為 14.86 美元。</p>
<p><strong>獲取我們關於 OSCR 的最新研究報告</strong></p>
<h2>Oscar Health 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Oscar Health, Inc.在美國運營，提供健康保險。該公司在個人和小型團體市場提供健康計劃，以及 +Oscar，一個技術驅動的平台，幫助提供者和支付方直接實現向基於價值的護理轉型。它還提供再保險產品。</p>
<h2>推薦故事</h2>
<ul>
<li>五隻我們更看好的股票，而不是 Oscar Health</li>
<li>股票市場行業：它們是什麼以及有多少個？</li>
<li>利用 2026 年人工智能基礎設施收益的高增長 ETF</li>
<li>內部交易 - 您需要知道的事項</li>
<li>強勁的季度，疲軟的反應：為什麼 GitLab 的股票下跌</li>
<li>ESG 股票，投資者應瞭解的事項</li>
<li>特斯拉開始 12 月的三個跡象</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>您現在應該投資 1,000 美元在 Oscar Health 嗎？</h2>
<p>在您考慮 Oscar Health 之前，您需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Oscar Health 並不在名單上。</p>
<p>儘管 Oscar Health 目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

OSCR

<p>Oscar Health 內部人士 Mario Schlosser 以每股 16.59 美元的價格出售了 23,965 股，總計 397,579.35 美元，減少了 4.78% 的持股比例。他現在擁有 477,183 股，價值 7,916,465.97 美元。此次出售在 SEC 文件中披露。Schlosser 之前在 11 月 11 日和 9 月 22 日出售過股票。還強調了 Oscar Health 的股票表現和機構投資者活動，以及分析師的評級和價格目標</p>

<p>Oscar Health, Inc. (NYSE:OSCR - Get Free Report) insider Mario Schlosser sold 23,965 shares of the firm's stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $397,579.35. Following the completion of the sale, the insider owned 477,183 shares in the company, valued at $7,916,465.97. This represents a 4.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is accessible through this link.</p>
<div class="lb-trans"><p>Oscar Health, Inc.（紐約證券交易所代碼：OSCR - 獲取免費報告）內部人士 Mario Schlosser 於 12 月 2 日（星期二）出售了 23,965 股公司的股票。該股票的平均售價為 16.59 美元，總交易額為 397,579.35 美元。出售完成後，該內部人士在公司持有 477,183 股，價值 7,916,465.97 美元。這代表其持股比例減少了 4.78%。該交易已在與證券交易委員會的法律文件中披露，您可以通過此鏈接訪問。</p>
</div><ul>
<li>5 Small Cap Stocks With Explosive Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只具有爆炸性上漲潛力的小型股</li>
</ul>
</div><p>Mario Schlosser also recently made the following trade(s):</p>
<div class="lb-trans"><p>Mario Schlosser 最近還進行了以下交易：</p>
</div><ul>
<li>On Tuesday, November 11th, Mario Schlosser sold 286,182 shares of Oscar Health stock. The stock was sold at an average price of $15.27, for a total value of $4,369,999.14.</li>
<li>On Monday, September 22nd, Mario Schlosser sold 395,000 shares of Oscar Health stock. The shares were sold at an average price of $18.43, for a total value of $7,279,850.00.</li>
</ul>
<div class="lb-trans"><ul>
<li>在 11 月 11 日（星期二），Mario Schlosser 出售了 286,182 股 Oscar Health 股票。該股票的平均售價為 15.27 美元，總價值為 4,369,999.14 美元。</li>
<li>在 9 月 22 日（星期一），Mario Schlosser 出售了 395,000 股 Oscar Health 股票。該股票的平均售價為 18.43 美元，總價值為 7,279,850.00 美元。</li>
</ul>
</div><h2>Oscar Health Stock Performance</h2>
<div class="lb-trans"><h2>Oscar Health 股票表現</h2>
</div><p>Shares of OSCR stock traded up $0.07 during mid-day trading on Thursday, reaching $17.17. The stock had a trading volume of 7,737,399 shares, compared to its average volume of 14,589,062. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.80. The firm has a market cap of $4.55 billion, a PE ratio of -15.33 and a beta of 1.88. The firm's 50 day simple moving average is $18.08 and its 200 day simple moving average is $16.93. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 0.67.</p>
<div class="lb-trans"><p>OSCR 股票在週四的午盤交易中上漲了 0.07 美元，達到 17.17 美元。該股票的交易量為 7,737,399 股，而其平均交易量為 14,589,062 股。Oscar Health, Inc.的股價一年低點為 11.20 美元，一年高點為 23.80 美元。該公司的市值為 45.5 億美元，市盈率為-15.33，貝塔值為 1.88。該公司的 50 日簡單移動平均線為 18.08 美元，200 日簡單移動平均線為 16.93 美元。公司的速動比率為 0.92，流動比率為 0.92，債務與股本比率為 0.67。</p>
</div><p>Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, topping the consensus estimate of ($0.55) by $0.02. The firm had revenue of $2.93 billion during the quarter, compared to analysts' expectations of $3.09 billion. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.Oscar Health's quarterly revenue was up 23.2% compared to the same quarter last year. During the same period last year, the business earned ($0.22) earnings per share. On average, analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current year.</p>
<div class="lb-trans"><p>Oscar Health（紐約證券交易所代碼：OSCR - 獲取免費報告）最近在 11 月 6 日（星期四）發佈了其財報。公司報告本季度每股收益（EPS）為（0.53）美元，超出市場共識預期的（0.55）美元，超出幅度為 0.02 美元。該季度公司的收入為 29.3 億美元，而分析師預期為 30.9 億美元。Oscar Health 的股本回報率為-21.50%，淨利潤率為-2.16%。與去年同期相比，Oscar Health 的季度收入增長了 23.2%。去年同期，該公司每股收益為（0.22）美元。分析師平均預測 Oscar Health, Inc.本年度將發佈 0.69 美元的每股收益。</p>
</div><h2>Institutional Investors Weigh In On Oscar Health</h2>
<div class="lb-trans"><h2>機構投資者對 Oscar Health 的看法</h2>
</div><p>A number of institutional investors have recently made changes to their positions in OSCR. American Century Companies Inc. increased its position in Oscar Health by 89.0% during the third quarter. American Century Companies Inc. now owns 5,298,340 shares of the company's stock worth $100,298,000 after buying an additional 2,495,691 shares during the last quarter. Nuveen LLC acquired a new position in shares of Oscar Health during the 1st quarter worth approximately $29,684,000. Farallon Capital Management LLC increased its holdings in shares of Oscar Health by 146.5% during the 3rd quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company's stock worth $68,886,000 after acquiring an additional 2,163,000 shares during the last quarter. Thrive Capital Management LLC raised its stake in Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock valued at $85,258,000 after acquiring an additional 1,588,395 shares during the period. Finally, State of Michigan Retirement System bought a new stake in Oscar Health in the 3rd quarter valued at $27,448,000. 75.70% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>一些機構投資者最近對 OSCR 的持倉進行了調整。美國世紀公司在第三季度將其在 Oscar Health 的持倉增加了 89.0%。美國世紀公司目前擁有 5,298,340 股該公司的股票，價值 100,298,000 美元，此前在上個季度又購買了 2,495,691 股。Nuveen LLC 在第一季度獲得了 Oscar Health 的新持倉，價值約 29,684,000 美元。Farallon Capital Management LLC 在第三季度將其在 Oscar Health 的持倉增加了 146.5%。Farallon Capital Management LLC 目前擁有 3,639,000 股該公司的股票，價值 68,886,000 美元，此前在上個季度又購買了 2,163,000 股。Thrive Capital Management LLC 在第四季度將其在 Oscar Health 的持倉提高了 33.4%。Thrive Capital Management LLC 目前擁有 6,343,617 股該公司的股票，價值 85,258,000 美元，此前在該期間又購買了 1,588,395 股。最後，密歇根州退休系統在第三季度購買了 Oscar Health 的新股份，價值 27,448,000 美元。75.70% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師的升級和降級</h2>
</div><p>Several research analysts recently issued reports on the stock. Wells Fargo &amp; Company dropped their price target on shares of Oscar Health from $14.00 to $11.00 and set an &#34;underweight&#34; rating for the company in a research report on Thursday, November 13th. The Goldman Sachs Group assumed coverage on Oscar Health in a report on Tuesday, October 14th. They issued a &#34;neutral&#34; rating and a $17.00 target price for the company. Piper Sandler raised Oscar Health from a &#34;neutral&#34; rating to an &#34;overweight&#34; rating and boosted their price target for the company from $13.00 to $25.00 in a research note on Tuesday, November 25th. UBS Group upped their price target on Oscar Health from $11.00 to $12.00 and gave the company a &#34;sell&#34; rating in a research report on Friday, November 7th. Finally, Barclays increased their price objective on Oscar Health from $11.00 to $13.00 and gave the stock an &#34;underweight&#34; rating in a research note on Monday, November 10th. One analyst has rated the stock with a Buy rating, five have issued a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat.com, Oscar Health currently has a consensus rating of &#34;Reduce&#34; and a consensus price target of $14.86.</p>
<div class="lb-trans"><p>幾位研究分析師最近對該股票發佈了報告。富國銀行將 Oscar Health 的目標股價從 14.00 美元下調至 11.00 美元，並在 11 月 13 日（星期四）的研究報告中對該公司給予了 “減持” 評級。高盛集團在 10 月 14 日（星期二）對 Oscar Health 進行了覆蓋，給予了 “中性” 評級和 17.00 美元的目標價格。派珀·桑德勒將 Oscar Health 的評級從 “中性” 上調至 “增持”，並在 11 月 25 日（星期二）的研究報告中將其目標價格從 13.00 美元提高至 25.00 美元。瑞銀集團將 Oscar Health 的目標價格從 11.00 美元上調至 12.00 美元，並在 11 月 7 日（星期五）的研究報告中給予該公司 “賣出” 評級。最後，巴克萊將 Oscar Health 的目標價格從 11.00 美元上調至 13.00 美元，並在 11 月 10 日（星期一）的研究報告中給予該股票 “減持” 評級。一位分析師對該股票給予了買入評級，五位分析師給予了持有評級，五位分析師給予了賣出評級。根據 MarketBeat.com 的數據，Oscar Health 目前的共識評級為 “減持”，共識目標價格為 14.86 美元。</p>
</div><p><strong>Get Our Latest Research Report on OSCR</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於 OSCR 的最新研究報告</strong></p>
</div><h2>Oscar Health Company Profile</h2>
<div class="lb-trans"><h2>Oscar Health 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.</p>
<div class="lb-trans"><p>Oscar Health, Inc.在美國運營，提供健康保險。該公司在個人和小型團體市場提供健康計劃，以及 +Oscar，一個技術驅動的平台，幫助提供者和支付方直接實現向基於價值的護理轉型。它還提供再保險產品。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Oscar Health</li>
<li>Stock Market Sectors: What Are They and How Many Are There?</li>
<li>Tap Into 2026 AI Infrastructure Gains With This High-Growth ETF</li>
<li>Insider Trading - What You Need to Know</li>
<li>Strong Quarter, Weak Reaction: Why GitLab Shares Dropped</li>
<li>ESG Stocks, What Investors Should Know</li>
<li>3 Signs Tesla Is Starting December on the Front Foot</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，而不是 Oscar Health</li>
<li>股票市場行業：它們是什麼以及有多少個？</li>
<li>利用 2026 年人工智能基礎設施收益的高增長 ETF</li>
<li>內部交易 - 您需要知道的事項</li>
<li>強勁的季度，疲軟的反應：為什麼 GitLab 的股票下跌</li>
<li>ESG 股票，投資者應瞭解的事項</li>
<li>特斯拉開始 12 月的三個跡象</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2>
<div class="lb-trans"><h2>您現在應該投資 1,000 美元在 Oscar Health 嗎？</h2>
</div><p>Before you consider Oscar Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考慮 Oscar Health 之前，您需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Oscar Health 並不在名單上。</p>
</div><p>While Oscar Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>儘管 Oscar Health 目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Oscar Health (NYSE:OSCR) 內部人士 Mario Schlosser 出售了 23,965 股股票